2019 Ioversol Market: World Business Growth, Demand, Trends, Key Players (Liebel-Flarsheim, Guerbet, Jiangsu) | Future Outlook 2023

Ioversol Market 2019 Report analyses the Industry Status, Size, Share, Emerging Trends, Growth Opportunity, Competition landscape and Forecast to 2023. This report also provides data on Patterns, Improvements, Target Business Sectors, Limits and Advancements.

Global Ioversol Market overview:

Detailed Study on Ioversol Market is growing at a CAGR during Forecasts year 2023. This Report covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Get Access to Report Sample @ https://www.businessindustryreports.com/sample-request/190899 .

This report studies the Global Ioversol is an Organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows Blood Vessels, Organs, and other non-bony tissues to be seen more clearly on a CT scan or other Radiologic (X-ray) examination. This unique property of Ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the Heart, Brain, and Blood Vessels. Ioversol (INN) is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups.

The Global Ioversol Market is segmented on the basis of Product Type, Application, End Use Industry and Region. On the Basis of Product Type segment, the Ioversol Market is sub segmented into Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240), Ioversol 64% Injectable Solution (Optiray 300), Ioversol 68% Injectable Solution (Optiray 320), Ioversol 74% Injectable Solution (Optiray 350). Based on End Use Industry segment, the Ioversol Market is sub segmented into X-Ray (Angiography, Urography, Tomography, Others), CT Scan, Brain Disorders, Blood Vessel Disorders, Heart Disorders.

Furthermore, it offers a detailed description and business profiles of leading key players operating in the global regions. It includes an overview of companies, contact information, methodologies, revenue generation, and successful strategies. North America, Latin America, Asia-Pacific, Africa, and Europe have been analyzed to get better insights about target market across the globe.

Some of the major players that operate in the Global Ioversol Market are Liebel-Flarsheim Company, Guerbet, Jiangsu, Hengrui Medicine, Mallinckrodt Pharmaceuticals, Ultraject.

Latest Industry Updates:

Guerbet:- A global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed a new agreement with IBM Watson Health to co-develop and co-commercialize an artificial intelligence (AI) solution to help clinicians diagnose and monitor patients with prostate cancer. This agreement follows the first agreement signed in July 2018 between the two companies with the aim of using an artificial intelligence program to help clinicians diagnose and monitor patients with liver cancer.

Under this second program, Guerbet and IBM will work to develop a tool using artificial intelligence with the goal of helping to detect, segment, characterize and monitor lesions over time. This AI approach may allow for faster and more informed diagnosis of prostate cancer. Prostate cancer is the second most commonly diagnosed cancer in men (13.5% of male cancer diagnoses worldwide according to the WHO). i The number of prostate MRIs is currently increasing by more than 10% per year, and a 2017 Lancet clinical studyii has shown that 27% of biopsies may be avoided and 18% of unseen cancers detected by using multiparameter MRI.

“The main diagnostic challenge with prostate cancer lies in identifying cancers requiring rapid treatment and those requiring only active surveillance, while avoiding unnecessary biopsies,iii said David Gruen, M.D., Chief Medical Officer, Imaging, IBM Watson Health. “For this reason, optimal patient outcomes depend on the rapid and accurate diagnosis and treatments that AI technologies can potentially help provide."

Get Best Discount On This Report @ https://www.businessindustryreports.com/check-discount/190899.

Table of Contents:

Section 1 Ioversol Product Definition

Section 2 Global Ioversol Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Ioversol Shipments

2.2 Global Manufacturer Ioversol Business Revenue

2.3 Global Ioversol Market Overview

Section 3 Manufacturer Ioversol Business Introduction

……………………..

3.2 Guerbet Ioversol Business Introduction

3.2.1 Guerbet Ioversol Shipments, Price, Revenue and Gross profit 2014-2018

3.2.2 Guerbet Ioversol Business Distribution by Region

3.2.3 Interview Record

3.2.4 Guerbet Ioversol Business Overview

3.2.5 Guerbet Ioversol Product Specification

………………. Request free sample to get a complete Table of Content

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

This release was published on openPR.